Previous Close | 3.3 |
1-Year Change | -27.95% |
6-Months Change | -78.56% |
3-Months Change | -19.9% |
Moving Avg (50d) | 3.9744 |
Moving Avg (200d) | 9.7161 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 207.0M |
Beta (3-Years) | 1.38 |
Revenue Growth (ttm) | -73.1% |
Net Profit Margin (ttm) | -332.47% |
Return On Assets (ttm) | -67.8% |
EPS (ttm) | -2.2 |
PE Ratio (ttm) | -1.5 |
Dividend Yield | % |
Asset Description: | MacroGenics, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
3.366 | 3.465 | 3.531 | 3.63 | 3.795 | 3.96 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |